Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in the West.
The prevalence and severity of NAFLD is higher and the prognosis worse in patients with …

Background Patients with psoriasis are at risk of non‐alcoholic fatty liver disease (NAFLD)
and likely liver fibrosis. Objective Investigate the prevalence of NAFLD in patients with …

Nonalcoholic fatty liver disease (NAFLD) has been found to be highly prevalent in psoriatic
patients. Adult onset psoriasis could be divided into either early or late onset psoriasis. The …

Psoriasis is a chronic inflammatory immune-mediated skin diseases which is frequently
associated to comorbidities. Non-alcoholic fatty liver disease (NAFLD) is defined as an …

Abstract Background/Objectives Several studies have reported that non‐alcoholic fatty liver
disease (NAFLD) is more frequent in patients with psoriasis, but few have reviewed the …

Purpose Chronic plaque psoriasis is associated with the presence of non-alcoholic fatty liver
disease (NAFLD), but the magnitude of this association remains currently uncertain. We …

Psoriasis is a systemic inflammatory disease associated with a variety of comorbidities. It
has been shown that psoriasis patients have an increased incidence of nonalcoholic fatty …

Psoriasis is an immune‐mediated systemic inflammatory disease that is not limited to the
skin but may be associated with arthritis, cardiovascular diseases, metabolic syndrome …

Abstract Background/Objectives Psoriasis patients have a higher risk of liver abnormalities
such as non‐alcoholic fatty liver disease (NAFLD), drug‐induced hepatitis, alcoholic …

Patients with psoriasis are at an increased risk for nonalcoholic fatty liver disease (NAFLD)
compared with the general population. However, the pathophysiology underlying this …